EUVIMEDEUVIMED entdecken
Open Access

Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors

Mathew Schneider, Carrie O'Connor, Xun Bao, Md Junayed Nayeen, Tejashree Magdum, Abhishekh Sharma, Jing Li, Seongho Kim, Charles E Dann, Aleem Gangjee, Zhanjun Hou, Larry H Matherly

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Mathew Schneider und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. Hauptthemen laut MEDLINE: Glycine Hydroxymethyltransferase, Mitochondria, Folic Acid Antagonists, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Duquesne University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One-carbon (C1) metabolism includes cytosolic and mitochondrial pathways connected by interchange between serine, glycine, and formate. Mitochondrial C1 metabolism through serine hydroxymethyltransferase (SHMT) 2 generates glycine and C1 units for de novo nucleotide biosynthesis in the cytosol, whereas cytosolic SHMT1 consumes C1 units and glycine. Folates and classical antifolates are transported into tumors by facilitative folate transporters (reduced folate carrier [RFC] and proton-coupled folate transporter [PCFT]) and are metabolized to polyglutamates by folylpolyglutamate synthetase (FPGS). Folate transporter-null HeLa cells were engineered to express RFC under the control of a tetracycline-inducible promoter. Constitutive expression of PCFT and/or FPGS increased cytosolic and mitochondrial folates over that of RFC alone. By targeted metabolomics, the C1 flux in mitochondria through SHMT2 paralleled RFC transport and folate accumulation in mitochondria and cytosol, whereas the SHMT1 flux was constant. Expression of PCFT resulted in further increased C1 flux through SHMT2, in excess of SHMT1. In vitro inhibition of cell proliferation by targeting SHMT1/2 with pyrrolo[3,2-d]pyrimidine antifolates (eg, AGF347) decreased with increasing RFC and with PCFT. Inhibition by AGF347 (not SHIN1/2) was stimulated with ectopic FPGS, accompanying increased AGF347 polyglutamates; decreased sensitivities were seen for nonclassical SHMT1/2 inhibitors (SHIN1/2), which are neither substrates for facilitative transport nor polyglutamylation. Our results document the complex interrelationships among (anti)folate membrane transport, polyglutamylation, and C1 fluxes through SHMT1 and SHMT2. They also demonstrate the profound impact of physiologic folates on antitumor activities and the extraordinary promise of multitargeted pyrrolo[3,2-d]pyrimidine antifolates for cancer therapy. SIGNIFICANCE STATEMENT: Novel pyrrolo[3,2-d]pyrimidine antifolates typified by AGF347 target serine hydroxymethyltransferase (SHMT) 2 in the mitochondria and SHMT1 and de novo purine biosynthesis in the cytosol. This manuscript documents the complex interrelationships among (anti)folate membrane transport, polyglutamylation, and one-carbon fluxes through SHMT1 and SHMT2 in the context of physiologic folate levels. The results document the therapeutic promise of classical multitargeted pyrrolo[3,2-d]pyrimidine antifolates typified by AGF347. These novel compounds offer an exciting new platform for one-carbon-targeted drug development for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycine HydroxymethyltransferaseMitochondriaFolic Acid AntagonistsNeoplasmsCarbonHumansHeLa CellsFolic AcidCytosolReduced Folate Carrier ProteinProton-Coupled Folate TransporterPeptide Synthases

Stichwörter der Autor:innen

AntifolateFolylpolyglutamate synthetaseOne-carbon metabolismProton-coupled folate transporterReduced folate carrierSerine hydroxymethyltransferase 2

Substanzen

Glycine HydroxymethyltransferaseFolic Acid AntagonistsSHMT protein, humanCarbonFolic AcidReduced Folate Carrier ProteinProton-Coupled Folate TransporterPeptide Synthasesfolylpolyglutamate synthetase

Autor:innen und Institutionen

  • Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania.
  • Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
  • Department of Chemistry, Indiana University, Bloomington, Indiana.
  • Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan. Electronic address: houz@karmanos.org.
  • Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan; Department of Pharmacology, Wayne State Uni…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • Duquesne University
  • National Institutes of Health National Cancer Institute
  • Cancer Research Institute

Zitieren

APA

Schneider, M., O'Connor, C., Bao, X., Nayeen, M. J., Magdum, T., Sharma, A., Li, J., Kim, S., Dann, C. E., Gangjee, A., Hou, Z., & Matherly, L. H. (2025). Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100120

Vancouver

Schneider M, O'Connor C, Bao X, Nayeen MJ, Magdum T, Sharma A, et al. Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100120

BibTeX
@article{Schneider2025,
  author = {Schneider, Mathew and O'Connor, Carrie and Bao, Xun and Nayeen, Md Junayed and Magdum, Tejashree and Sharma, Abhishekh and Li, Jing and Kim, Seongho and Dann, Charles E and Gangjee, Aleem and Hou, Zhanjun and Matherly, Larry H},
  title = {Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100120}
}
Kostenlos starten →